CCC
ZTS icon

Crescent Capital Consulting’s Zoetis ZTS Stock Holding History

Crescent Capital Consulting’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$14K Hold
57
– – ﹤0.01% 377
2021
Q3 		$11K Hold
57
– – ﹤0.01% 418
2021
Q2 		$11K Sell
57
-21
-27% -$3.65K ﹤0.01% 367
2021
Q1 		$12K Buy
78
+58
+290% +$9.19K ﹤0.01% 377
2020
Q4 		$3K Buy
+20
New +$3.25K ﹤0.01% 395

Other funds holding ZTS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Crescent Capital Consulting's ZTS Position: Q4 2021 in Review

Crescent Capital Consulting held its Zoetis (ZTS) position steady in Q4 2021 at 57 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Crescent Capital Consulting first reported a position in ZTS in Q4 2020 and has held it in 5 quarters since. 1,673 funds tracked by Wall St. Rank hold ZTS as of Q4 2021.

  • Crescent Capital Consulting held 57 shares of Zoetis worth $14K as of Q4 2021.
  • Crescent Capital Consulting left its Zoetis share count unchanged in Q4 2021.
  • Zoetis made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #377 holding.
  • Crescent Capital Consulting first reported a position in Zoetis in Q4 2020 and has held it in 5 quarters since.
  • 1,673 funds tracked by Wall St. Rank held Zoetis as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.